Search research articles
Contact Us
Filters
Showing results (31-40 of 51) with videos related to
Page
of 6
Sort By:
Journal of Medical Virology
|
July 14, 2021
SARS-CoV-2 reinfection in a cancer patient with a defective neutralizing humoral response
Cinzia Borgogna, Marco De Andrea, Gloria Griffante, et al.
European Urology Oncology
|
August 13, 2023
Combining PARP Inhibitors and Androgen Receptor Signalling Inhibitors in Metastatic Prostate Cancer: A Quantitative Synthesis and Meta-analysis
Carlo Messina, Emilio Francesco Giunta, Alessio Signori, et al.
Scientific Reports
|
October 18, 2023
Untargeted lipidomics reveal association of elevated plasma C18 ceramide levels with reduced survival in metastatic castration-resistant prostate cancer patients
Carlo Cattrini, Marcello Manfredi, Paola Barboro, et al.
Therapeutic Advances in Urology
|
July 26, 2023
The role of mean corpuscular volume and red cell distribution width in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors: the MARECAP retrospective study
Chiara Tommasi, Giulia Scartabellati, Diana Giannarelli, et al.
Anti-Cancer Drugs
|
December 20, 2022
The impact of proton-pump inhibitors administered with tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma
Sebastiano Buti, Chiara Tommasi, Giulia Scartabellati, et al.
Clinical Genitourinary Cancer
|
December 11, 2024
Development and Validation of Prognostic Model for Metastatic Castration-Resistant Prostate Cancer Patients Treated With First-Line Abiraterone or Enzalutamide
Orazio Caffo, Umberto Basso, Carlo Cattrini, et al.
Future Oncology (London, England)
|
April 28, 2025
Prognostic factors of long-term response to androgen receptor signaling inhibitors used as first-line treatment for mCRPC
Antonello Veccia, Umberto Basso, Carlo Cattrini, et al.
Cancers
|
April 27, 2024
Development and Validation of an Inflammatory Prognostic Index to Predict Outcomes in Advanced/Metastatic Urothelial Cancer Patients Receiving Immune Checkpoint Inhibitors
Sara Mokbel, Giuilia Baciarello, Pernelle Lavaud, et al.
Therapeutic Advances in Urology
|
April 19, 2024
Assessing the effectiveness and safety of lenvatinib and everolimus in advanced renal cell carcinoma: insights from the RELIEVE study's analysis of heavily pretreated patients
Sebastiano Buti, Alessandro Olivari, Cristina Masini, et al.
Reviews in Cardiovascular Medicine
|
August 14, 2024
Serum Biomarkers to Dynamically Predict the Risk of Cardiovascular Events in Patients under Oncologic Therapy. A Multicenter Observational Study
Nicoletta Provinciali, Marco Piccininno, Giacomo Siri, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 51) with videos related to
Sort By:
Page
of 6
Journal of Medical Virology
|
July 14, 2021
SARS-CoV-2 reinfection in a cancer patient with a defective neutralizing humoral response
Cinzia Borgogna, Marco De Andrea, Gloria Griffante, et al.
European Urology Oncology
|
August 13, 2023
Combining PARP Inhibitors and Androgen Receptor Signalling Inhibitors in Metastatic Prostate Cancer: A Quantitative Synthesis and Meta-analysis
Carlo Messina, Emilio Francesco Giunta, Alessio Signori, et al.
Scientific Reports
|
October 18, 2023
Untargeted lipidomics reveal association of elevated plasma C18 ceramide levels with reduced survival in metastatic castration-resistant prostate cancer patients
Carlo Cattrini, Marcello Manfredi, Paola Barboro, et al.
Therapeutic Advances in Urology
|
July 26, 2023
The role of mean corpuscular volume and red cell distribution width in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors: the MARECAP retrospective study
Chiara Tommasi, Giulia Scartabellati, Diana Giannarelli, et al.
Anti-Cancer Drugs
|
December 20, 2022
The impact of proton-pump inhibitors administered with tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma
Sebastiano Buti, Chiara Tommasi, Giulia Scartabellati, et al.
Clinical Genitourinary Cancer
|
December 11, 2024
Development and Validation of Prognostic Model for Metastatic Castration-Resistant Prostate Cancer Patients Treated With First-Line Abiraterone or Enzalutamide
Orazio Caffo, Umberto Basso, Carlo Cattrini, et al.
Future Oncology (London, England)
|
April 28, 2025
Prognostic factors of long-term response to androgen receptor signaling inhibitors used as first-line treatment for mCRPC
Antonello Veccia, Umberto Basso, Carlo Cattrini, et al.
Cancers
|
April 27, 2024
Development and Validation of an Inflammatory Prognostic Index to Predict Outcomes in Advanced/Metastatic Urothelial Cancer Patients Receiving Immune Checkpoint Inhibitors
Sara Mokbel, Giuilia Baciarello, Pernelle Lavaud, et al.
Therapeutic Advances in Urology
|
April 19, 2024
Assessing the effectiveness and safety of lenvatinib and everolimus in advanced renal cell carcinoma: insights from the RELIEVE study's analysis of heavily pretreated patients
Sebastiano Buti, Alessandro Olivari, Cristina Masini, et al.
Reviews in Cardiovascular Medicine
|
August 14, 2024
Serum Biomarkers to Dynamically Predict the Risk of Cardiovascular Events in Patients under Oncologic Therapy. A Multicenter Observational Study
Nicoletta Provinciali, Marco Piccininno, Giacomo Siri, et al.
Page
of 6